J&J partners with AI startup to identify early lung cancer cases
J&J partners with AI startup to identify early lung cancer cases
A Johnson & Johnson division focused on developing tools to combat lung cancer is partnering with a clinical decision-support startup that recently achieved regulatory clearance for an early detection tool, the companies announced Wednesday.